
Pharma Pulse 6/28/24: Acupuncture Decreases Hot Flashes, The Benefits of Using AI in Data Management & more
The latest news for pharma industry insiders.
In part 3 of this video interview, Diane Lacroix, vice president, clinical data management, eClinical Solutions touches on some of the greatest benefits she has seen with the integration of artificial intelligence into data management.
Previous acupuncture studies have focused on European and American women, but little was known about breast cancer patients in Asia.
It started by centralizing all its proprietary AI technology on an internal platform, which CIO Marco Argenti said might have slowed it down at first but is now paying off.
The "Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-users and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering. The global cell and gene therapy CRO market is estimated to grow from $1.65 billion in 2024 to $3.51 billion by 2035, representing a CAGR of 7.1% during the forecast period 2024-2035.
Access to HCPs is tough - that's not news to anyone who has spent more than a few years in this industry. But how pharma organizations are using their access varies widely and can create a competitive edge.
Connected engagement models are allowing commercial organizations to make the most of the time they have with HCPs, strengthening relationships and keeping doors open.
Pharmaceutical Executive, thanks for having me to share my thoughts on this topic.
Have news you want us to share in Pharma Pulse? Reach out to Social
Media Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

